tiprankstipranks
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market

Chugai Pharmaceutical Co (CHGCF) Income Statement

Compare
17 Followers

Chugai Pharmaceutical Co Income Statement

Last quarter (Q4 2024), Chugai Pharmaceutical Co's total revenue was ¥300.60B, an increase of 9.78% from the same quarter last year. In Q4, Chugai Pharmaceutical Co's net income was ¥91.60B. See Chugai Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B¥ 786.95B
Gross Profit
¥ 831.20B¥ 698.06B¥ 783.70B¥ 661.61B¥ 513.48B
Operating Expenses
¥ 289.20B¥ 258.89B¥ 250.39B¥ 239.72B¥ 212.25B
Depreciation and Amortization
¥ 26.39B¥ 31.74B¥ 31.43B¥ 30.87B¥ 30.48B
EBITDA
¥ 568.39B¥ 475.64B¥ 562.66B¥ 450.30B¥ 328.72B
Operating Income
¥ 542.00B¥ 439.17B¥ 533.31B¥ 421.90B¥ 301.23B
Other Income/Expenses
¥ 1.03B¥ 4.65B¥ -2.14B¥ -2.51B¥ -3.04B
Pretax Income
¥ 543.03B¥ 443.82B¥ 531.17B¥ 419.38B¥ 298.19B
Net Income
¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B¥ 214.73B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 235.39¥ 197.83¥ 227.64¥ 184.29¥ 130.66
Diluted EPS
¥ 235.36¥ 197.80¥ 227.57¥ 184.17¥ 130.53
Weighted Average Shares Outstanding
1.65B 1.65B 1.64B 1.64B 1.64B
Weighted Average Shares Outstanding (Diluted)
1.65B 1.65B 1.65B 1.65B 1.65B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis